Oriola
0.938
EUR
+2.51 %
OKDBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
7,626 following
+2.51%
+0.21%
-0.85%
+0.54%
-13.79%
-7.86%
-53.45%
-55.12%
-49%
www.oriola.com/investors
Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.
P/E (adj.) (24e)
25.05
EV/EBIT (adj.) (24e)
4.15
P/B (24e)
1.08
Dividend yield-% (24e)
8.53 %
Target price
1.00 EUR
Recommendation
Accumulate
Updated
31.10.2024
NASDAQ Helsinki
OKDBV
Daily low / high price
0.908 / 0.938
EUR
Market cap
170.23M EUR
Turnover
62.22K EUR
Volume
68K
Business risk
Valuation risk
Current
Previous
Analyst
Rauli Juva
Analyst
Latest videos
Financial calendar
Annual report
04.03.2025
General meeting
02.04.2025
Interim report
29.04.2025
Interim report
18.07.2025
Interim report
30.10.2025
Income statement
| 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,800.8 | 1,882.4 | 1,841.4 | 1,493.8 | 1,685.9 | 1,776.7 | 1,862.3 | 1,952.0 |
| growth-% | 4.6 % | 4.5 % | -2.2 % | -18.9 % | 12.9 % | 5.4 % | 4.8 % | 4.8 % |
| EBITDA | 63.1 | 65.4 | 68.6 | 30.1 | 27.7 | 26.7 | 28.1 | 30.2 |
| EBIT (adj.) | 21.0 | 26.3 | 34.5 | 16.7 | 21.8 | 24.0 | 25.5 | 27.0 |
| EBIT | 20.4 | 20.5 | 40.2 | -5.3 | 14.1 | 16.0 | 17.5 | 19.0 |
| Profit before taxes | 14.3 | 14.7 | 35.4 | -17.6 | 1.2 | 10.5 | 16.5 | 18.6 |
| Net income | 11.3 | 11.3 | 27.4 | -20.7 | -0.5 | 8.2 | 13.8 | 15.4 |
| EPS (adj.) | 0.07 | 0.09 | 0.12 | 0.01 | 0.04 | 0.08 | 0.11 | 0.12 |
| growth-% | -9.6 % | 44.4 % | 26.9 % | -94.1 % | 434.6 % | 112.5 % | 38.5 % | 8.2 % |
| Dividend | 0.03 | 0.04 | 0.06 | 0.07 | 0.08 | 0.09 | 0.10 | 0.06 |
| Dividend ratio | 48.2 % | 64.2 % | 39.7 % | -61.2 % | -3,085.9 % | 199.2 % | 131.9 % | 75.0 % |
Profitability and return on capital
| 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
|---|---|---|---|---|---|---|---|---|
| EBITDA-% | 3.5 % | 3.5 % | 3.7 % | 2.0 % | 1.6 % | 1.5 % | 1.5 % | 1.5 % |
| EBIT-% (adj.) | 1.2 % | 1.4 % | 1.9 % | 1.1 % | 1.3 % | 1.4 % | 1.4 % | 1.4 % |
| EBIT-% | 1.1 % | 1.1 % | 2.2 % | -0.4 % | 0.8 % | 0.9 % | 0.9 % | 1.0 % |
| ROE | 6.9 % | 5.8 % | 12.4 % | -10.4 % | -0.3 % | 5.3 % | 9.1 % | 10.4 % |
| ROI | 5.0 % | 4.6 % | 10.2 % | -3.1 % | 3.1 % | 6.7 % | 9.6 % | 10.6 % |
Valuation
| 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
|---|---|---|---|---|---|---|---|---|
| Share price (EUR) | 1.90 | 2.01 | 1.72 | 0.92 | 0.94 | 0.94 | 0.94 | 0.94 |
| Shares | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 | 181.3 |
| Market cap | 344.5 | 364.5 | 311.9 | 166.8 | 170.1 | 170.1 | 170.1 | 170.1 |
| Enterprise value | 471.6 | 465.3 | 288.2 | 103.5 | 90.4 | 86.4 | 93.9 | 104.8 |
| EV/S | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 |
| EV/EBITDA | 7.5 | 7.1 | 4.2 | 3.4 | 3.3 | 3.2 | 3.3 | 3.5 |
| EV/EBIT (adj.) | 22.5 | 17.7 | 8.4 | 6.2 | 4.1 | 3.6 | 3.7 | 3.9 |
| EV/EBIT | 23.1 | 22.7 | 7.2 | - | 6.4 | 5.4 | 5.4 | 5.5 |
| P/E (adj.) | 29.1 | 21.3 | 14.4 | 131.3 | 25.0 | 11.8 | 8.5 | 7.9 |
| P/E | 30.6 | 32.3 | 11.4 | - | - | 20.8 | 12.4 | 11.1 |
| P/B | 2.0 | 1.7 | 1.4 | 1.0 | 1.1 | 1.1 | 1.1 | 1.2 |
| P/S | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Dividend yield | 1.6 % | 2.0 % | 3.5 % | 7.6 % | 8.5 % | 9.6 % | 10.7 % | 6.8 % |
| Equity ratio | 14.5 % | 19.8 % | 23.5 % | 18.3 % | 16.9 % | 15.8 % | 15.5 % | 14.6 % |
| Gearing ratio | 74.9 % | 46.5 % | -10.5 % | -12.0 % | -21.8 % | -25.4 % | -20.8 % | -13.8 % |
Quarter data
| Q4/23 | 2023 | Q1/24 | Q2/24 | Q3/24 | Q4/24e | 2024e | Q1/25e | Q2/25e | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 386.5 | 1,493.8 | 375.1 | 439.5 | 424.4 | 446.9 | 1,685.9 | ||
| EBITDA | 8.3 | 30.1 | 6.7 | 8.6 | 4.9 | 7.5 | 27.7 | ||
| EBIT | 5.3 | -5.3 | 3.7 | 5.7 | 0.2 | 4.5 | 14.1 | ||
| Profit before taxes | -0.8 | -17.6 | -2.0 | 2.8 | -2.2 | 2.5 | 1.2 | ||
| Net income | -2.7 | -20.7 | -2.3 | 1.9 | -1.9 | 1.9 | -0.5 |
ShowingAll content types
Oriola-KD Oyj, Q3'24
Oriola Oyj: Oriola Corporation's Interim Report January-September 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Oriola Oyj: Oriola Corporation to publish its Interim Report for January-September 2024 on 30 October 2024
Oriola Oyj: Change in Oriola Management Team: Hannes Hasselrot, Chief Commercial Officer, to leave Oriola
Oriola Oyj: Oriola appoints Tuomas Tiilikainen as Chief Supply Chain Officer
Oriola Oyj: Publication schedule for Oriola Corporation's financial reporting in 2025
Oriola Oyj: Oriola appoints Mats Danielsson as Chief Financial Officer
Oriola Oyj: Changes in Oriola's Management Team: Timo Leinonen and Petri Boman to leave Oriola
Oriola Q2’24: Sales growth in both segments
